€100M round led by Index Ventures with participation from Greenoaks, Kaaf, SH, angels including Tobi Lütke and Antoine Griezmann, and corporate partner Belfius. Company reported €785,000,000 ARR in 2025, aiming for $1.16B ARR in 2026. Alan declared operational profitability in France and has reduced losses; net losses were $61M in 2023 and $56M in 2024.
About Alan
Paris-based digital health company combining health insurance, digital care, and preventive tools in one app to simplify reimbursements, care access, and personalised prevention.
Paris, France
Read Company ProfileFunding Rounds
| Amount | Date | Round | |
|---|---|---|---|
| €100 M | Mar, 2026 | series-e+ Current | Viewing |
| €400 M | Jun, 2026 | unspecified | View |
Frequently Asked Questions
What type of funding round did Alan raise?
Alan raised a series-e+ round.
How much did Alan raise in its series-e+?
Alan raised $100,000,000 EUR in its series-e+.
When did Alan raise its series-e+?
Alan raised its series-e+ on 2026-03-11.
What was Alan's valuation after the series-e+?
Alan was valued at $5,000,000,000 EUR after the series-e+.
Who invested in Alan's series-e+?
The investors in Alan's series-e+ are: Index Ventures, Greenoaks, Kaaf, SH, Tobi Lütke, Antoine Griezmann, Belfius.
What type of investment was Alan's series-e+?
Alan's series-e+ was a equity investment.
How will Alan use the funds from its series-e+?
Alan plans to use the funds for: investment in technology and AI, international expansion, product improvements.